The 68 Ga/ 177 Lu-theragnostic concept in PSMA-targeting of metastatic castration –resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
ConclusionSerial PSA measurements and post-therapy 24 h WB scintigraphy seems to allow a sufficiently accurate follow-up of177Lu-PSMA-617-treated mCRPC patients whereas68Ga-PSMA-11 PET/CT should be performed for patient selection and final response assessment.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Liver | Nuclear Medicine | PET Scan | Prostate Cancer | Urology & Nephrology | Xerostomia